🚀 VC round data is live in beta, check it out!
Balsm Alofoq Valuation Multiples
Discover revenue and EBITDA valuation multiples for Balsm Alofoq and similar public comparables like iZafe Group, Jin Medical International, Farmaceutica Remedia, Ortivus and more.
Balsm Alofoq Overview
About Balsm Alofoq
Balsm Alofoq Medical Co operates in the medical sector. Its activities include medical services, specialized clinics and medical complexes, medical operations, and the import and supply of medical devices and supplies to all regions of the Kingdom of Saudi Arabia.
Founded
2012
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$14M
Balsm Alofoq Financials
Balsm Alofoq reported last fiscal year revenue of $5M and EBITDA of $1M.
In the same fiscal year, Balsm Alofoq generated $2M in gross profit, $1M in EBITDA, and $525K in net income.
Balsm Alofoq P&L
In the most recent fiscal year, Balsm Alofoq reported revenue of $5M and EBITDA of $1M.
Balsm Alofoq expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $5M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $2M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 38% | XXX | XXX | XXX |
| EBITDA | — | XXX | $1M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 19% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 13% | XXX | XXX | XXX |
| Net Profit | — | XXX | $525K | XXX | XXX | XXX |
| Net Margin | — | XXX | 10% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Balsm Alofoq Stock Performance
Balsm Alofoq has current market cap of $17M, and enterprise value of $14M.
Market Cap Evolution
Balsm Alofoq's stock price is $6.67.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $14M | $17M | 0.1% | XXX | XXX | XXX | $0.21 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBalsm Alofoq Valuation Multiples
Balsm Alofoq trades at 2.6x EV/Revenue multiple, and 14.1x EV/EBITDA.
Balsm Alofoq Financial Valuation Multiples
As of April 11, 2026, Balsm Alofoq has market cap of $17M and EV of $14M.
Equity research analysts estimate Balsm Alofoq's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Balsm Alofoq has a P/E ratio of 31.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $17M | XXX | $17M | XXX | XXX | XXX |
| EV (current) | $14M | XXX | $14M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 2.6x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 14.1x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 20.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 6.8x | XXX | XXX | XXX |
| P/E | — | XXX | 31.8x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (7.5x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Balsm Alofoq Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Balsm Alofoq Margins & Growth Rates
Balsm Alofoq's revenue in the last fiscal year grew by 3%.
Balsm Alofoq Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (40%) | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 7% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 25% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Balsm Alofoq Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| iZafe Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Jin Medical International | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| Ortivus | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Balsm Alofoq M&A Activity
Balsm Alofoq acquired XXX companies to date.
Last acquisition by Balsm Alofoq was on XXXXXXXX, XXXXX. Balsm Alofoq acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Balsm Alofoq
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBalsm Alofoq Investment Activity
Balsm Alofoq invested in XXX companies to date.
Balsm Alofoq made its latest investment on XXXXXXXX, XXXXX. Balsm Alofoq invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Balsm Alofoq
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Balsm Alofoq
| When was Balsm Alofoq founded? | Balsm Alofoq was founded in 2012. |
| Where is Balsm Alofoq headquartered? | Balsm Alofoq is headquartered in Saudi Arabia. |
| Is Balsm Alofoq publicly listed? | Yes, Balsm Alofoq is a public company listed on Tadawul. |
| What is the stock symbol of Balsm Alofoq? | Balsm Alofoq trades under 9620 ticker. |
| When did Balsm Alofoq go public? | Balsm Alofoq went public in 2024. |
| Who are competitors of Balsm Alofoq? | Balsm Alofoq main competitors are iZafe Group, Jin Medical International, Farmaceutica Remedia, Ortivus. |
| What is the current market cap of Balsm Alofoq? | Balsm Alofoq's current market cap is $17M. |
| What is the current revenue of Balsm Alofoq? | Balsm Alofoq's last fiscal year revenue is $5M. |
| What is the current EV/Revenue multiple of Balsm Alofoq? | Current revenue multiple of Balsm Alofoq is 2.6x. |
| Is Balsm Alofoq profitable? | No, Balsm Alofoq is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.